Video

Leiomyosarcoma Patient Discusses Treatment Roadmap, Challenges

Author(s):

Lauren Santye, Assistant Editor

Beth Wallace discusses various treatments for leiomyosarcoma, including doxorubicin (Adriamycin), nicknamed the red devil.

Beth Wallace discusses various treatments for leiomyosarcoma, including doxorubicin (Adriamycin), nicknamed the red devil.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Pharmacist and doctor -- Image credit: ake1150 | stock.adobe.com
Related Content
Immunoglobulin in IV | Image Credit: © Trsakaoe - stock.adobe.com
August 20th 2025

Immunoglobulin Replacement Therapy Fails to Lower Hospitalizations in CLL, Study Finds

Alexandra Gerlach, Associate Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
August 20th 2025

Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC

Alexandra Gerlach, Associate Editor Kevin Chen, PharmD Amanda Cass, PharmD, BCPS, BCOP
Focused Female Scientist Examining Digital Data Screen in Modern Laboratory | Image Credit: sarayut | stock.adobe.com
August 20th 2025

Advancing Precision Oncology Through Pharmacy-Led Innovation

Alana Hippensteele, Lead Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
August 20th 2025

Allen's Story: The Promising Potential of Intratumoral Immunotherapy

Alexandra Gerlach, Associate Editor
Diagnosis papers for chronic kidney disease (CKD) -- Image credit: Dzmitry | stock.adobe.com
August 20th 2025

UNI-494 Receives US Patent for Treatment of Chronic Kidney Disease

Gillian McGovern, Associate Editor
Professional pharmacists working together in modern drugstore | Image Credit: New Africa | stock.adobe.com
August 20th 2025

Adapting Oncology Pharmacy to the Age of AI and Drug Shortages

Alana Hippensteele, Lead Editor